EP1656094A2 — Methods of improving the safety of zonisamide therapy
Assigned to Eisai Co Ltd · Expires 2006-05-17 · 20y expired
What this patent protects
Methods to increase the safety of patients taking pharmaceutical formulations of zonisamide by providing information that increases the awareness of pancreatitis; as a possible side effect wherein both the patient and treating physicians and other medical care providers may monit…
USPTO Abstract
Methods to increase the safety of patients taking pharmaceutical formulations of zonisamide by providing information that increases the awareness of pancreatitis; as a possible side effect wherein both the patient and treating physicians and other medical care providers may monitor effectively for pancreatitis and methods for increasing the probability of a positive outcome in the few patients who experience pancreatitis associated with zonisamide therapy.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.